We serve Chemical Name:3-Bromothieno[3,2-c]pyridin-4(5H)-one CAS:799293-83-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Bromothieno[3,2-c]pyridin-4(5H)-one
CAS.NO:799293-83-7
Synonyms:3-bromo-5H-thieno[3,2-c]pyridin-4-one
Molecular Formula:C7H4BrNOS
Molecular Weight:230.08200
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:61.36000
Exact Mass:228.92000
LogP:2.76440
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3260 8 / PGIII
Packing Group:
Contact us for information like 3-bromo-5H-thieno[3,2-c]pyridin-4-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-bromo-5H-thieno[3,2-c]pyridin-4-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-bromo-5H-thieno[3,2-c]pyridin-4-one Use and application,3-bromo-5H-thieno[3,2-c]pyridin-4-one technical grade,usp/ep/jp grade.
Related News: After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API. 3-Bromothieno[3,2-c]pyridin-4(5H)-one manufacturer China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug. 3-Bromothieno[3,2-c]pyridin-4(5H)-one supplier “The synergies among our Regulatory, Clinical and Real-World Evidence (RWE) practices and CROS NT’s global biometrics capabilities will enhance Alira Health’s unique ability to serve clients across their solutions lifecycle,” said CEO Gabriele Brambilla in a statement. 3-Bromothieno[3,2-c]pyridin-4(5H)-one vendor “The synergies among our Regulatory, Clinical and Real-World Evidence (RWE) practices and CROS NT’s global biometrics capabilities will enhance Alira Health’s unique ability to serve clients across their solutions lifecycle,” said CEO Gabriele Brambilla in a statement. 3-Bromothieno[3,2-c]pyridin-4(5H)-one factory After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API.